Alpelisib in Intractable Non-Islet-Cell Tumor Hypoglycemia.

Avivit Cahn, Hagit Shoyhet-Smoilovsky, Matan Fischer, Aviad Zick, Yael Riahi, Shulamit Levenberg, Gil Leibowitz

    Research output: Contribution to journalReview articlepeer-review

    1 Scopus citations


    Alpelisib in Intractable Non-Islet-Cell Tumor Hypoglycemia This letter describes the use of alpelisib, a PI3 kinase inhibitor, to successfully treat severe hypoglycemia in a patient with intractable non-islet-cell tumor hypoglycemia.

    Original languageAmerican English
    Pages (from-to)1911-1913
    Number of pages3
    JournalNew England Journal of Medicine
    Issue number20
    StatePublished - 18 May 2023

    Bibliographical note

    Publisher Copyright:
    © 2023 Massachusetts Medical Society.


    • Clinical Medicine
    • Clinical Medicine General
    • Endocrinology
    • Endocrinology General
    • Hematology/Oncology
    • Treatments in Oncology


    Dive into the research topics of 'Alpelisib in Intractable Non-Islet-Cell Tumor Hypoglycemia.'. Together they form a unique fingerprint.

    Cite this